-
Study aim
-
Comparisson of the Efficacy of Ringer's Lactate Serum as a Base Solution in Modified Del Nido Cardioplegia with Standard Del Nido Cardioplegia on Myocardial Damage Markers and Clinical Outcomes in Patients Undergoing Coronary Artery Bypass Graft
-
Design
-
Randomized, single-blinded controlled trial, with parallel groups (allocation ratio 1:1).
-
Settings and conduct
-
This study is performed on patients who are candidates for coronary artery bypass surgery in Imam Hossein hospital (Tehran, Iran) in 1401. Eligible patients are divided into two groups (A and B) using a table of random numbers. In groups A and B, Ringer's lactate and plasmalite A solution are used for cardioplegia, respectively. Then, the markers of myocardial damage and the clinical outcomes of patients after surgery and at the admission to the intensive care unit are evaluated. In this single-blinded study, the patients are unaware of the allocation of individuals to the groups.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria are: Candidate patients for coronary artery bypass graft, Candidate patients for 3 to 4 vascular grafts, Age between 18 and 75 years, Written informed consent to participate in the study, An ejection fraction higher than 35% before surgery, and Lack of multi-organ failure before surgery.
Exclusion criteria are: Re-operation and Proven infection or inflammation within the last month
-
Intervention groups
-
In this study, Ringer's lactate solution is used to cardioplegia in group A (modified Del Nino). Also, in group B, plasmalit A solution is used to cardioplegia (Del Nino standard). Cardioplegic solution is a solution that is used to protect the myocardium during surgery and during the period when the heart is deprived of blood circulation.
-
Main outcome variables
-
Clinical outcomes; Myocardial damage markers